Quarterly report pursuant to Section 13 or 15(d)

SHAREOWNERS' EQUITY

v3.23.1
SHAREOWNERS' EQUITY
 3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
SHAREOWNERS' EQUITY SHAREOWNERS' EQUITY
Capital Stock, Additional Paid-In Capital, Retained Earnings and Non-Controlling Minority Interests
We are authorized to issue two classes of common stock, which are distinguished from each other primarily by their respective voting rights. Class A shares of UPS are entitled to 10 votes per share, whereas class B shares are entitled to one vote per share. Class A shares are primarily held by UPS employees and retirees, as well as trusts and descendants of the Company's founders, and these shares are fully convertible into class B shares at any time. Class B shares are publicly traded on the NYSE under the symbol “UPS”. Class A and B shares both have a $0.01 par value, and as of March 31, 2023, there were 4.6 billion class A shares and 5.6 billion class B shares authorized to be issued. Additionally, there are 200 million preferred shares authorized to be issued, with a par value of $0.01 per share. As of March 31, 2023, no preferred shares had been issued.
The following is a rollforward of our common stock, additional paid-in capital, retained earnings and non-controlling minority interests accounts for the three months ended March 31, 2023 and 2022 (in millions, except per share amounts):
Three Months Ended March 31: 2023 2022
  Shares Dollars Shares Dollars
Class A Common Stock:
Balance at beginning of period 134  $ 2  138  $ 2 
Stock award plans 3  —  4  — 
Common stock issuances 1  —  1  — 
Conversions of class A to class B common stock (3) —  (3) — 
Class A shares outstanding at end of period 135  $ 2  140  $ 2 
Class B Common Stock:
Balance at beginning of period 725  $ 7  732  $ 7 
Common stock purchases (4) —  (1) — 
Conversions of class A to class B common stock 3  —  3  — 
Class B shares outstanding at end of period 724  $ 7  734  $ 7 
Additional Paid-In Capital:
Balance at beginning of period $ —  $ 1,343 
Stock award plans 345  (35)
Common stock purchases (492) (260)
Common stock issuances 147  183 
Balance at end of period $ —  $ 1,231 
Retained Earnings:
Balance at beginning of period $ 21,326  $ 16,179 
Net income attributable to controlling interests 1,895  2,662 
Dividends ($1.62 and $1.52 per share) (1)
(1,453) (1,406)
Common stock purchases (258) — 
Other —  (2)
Balance at end of period $ 21,510  $ 17,433 
Non-Controlling Interests:
Balance at beginning of period $ 17  $ 16 
Change in non-controlling interest (2) 2 
Balance at end of period $ 15  $ 18 
(1) The dividend per share amount is the same for both class A and class B common stock. Dividends include $105 and $122 million as of March 31, 2023 and 2022, respectively, that were settled in shares of class A common stock.
We repurchased 4.1 and 1.2 million shares of class B common stock for $750 and $260 million during the three months ended March 31, 2023 and 2022, respectively. Repurchases of $751 and $254 million, respectively, are reported on the statements of consolidated cash flows due to the timing of settlements. These repurchases were completed as follows:
•In August 2021, the Board of Directors authorized the company to repurchase up to $5.0 billion of class A and class B common stock (the "2021 Authorization"). For the three months ended March 31, 2023 and 2022, we repurchased 0.5 and 1.2 million shares of class B common stock for $82 and $260 million, respectively, under this authorization.
•In January 2023, the Board of Directors terminated the 2021 Authorization and approved a new share repurchase authorization for $5.0 billion of class A and class B common stock (the "2023 Authorization"). For the three months ended March 31, 2023, we repurchased 3.6 million shares for $668 million under the 2023 Authorization. As of March 31, 2023, we had $4.3 billion available under this repurchase authorization.
We anticipate our share repurchases will total approximately $3.0 billion in 2023.
Future share repurchases may be in the form of accelerated share repurchase programs, open market purchases or other methods we deem appropriate. The timing of share repurchases will depend upon market conditions. Unless terminated earlier by the Board of Directors, this program will expire when we have purchased all shares authorized for repurchase under the program.
Movements in additional paid-in capital in respect of stock award plans comprise accruals for unvested awards, offset by adjustments for awards that vest during the period.
Accumulated Other Comprehensive Income (Loss)
We recognize activity in other comprehensive income for foreign currency translation adjustments, unrealized holding gains and losses on available-for-sale securities, unrealized gains and losses from derivatives that qualify as hedges of cash flows and unrecognized pension and postretirement benefit costs. The activity in accumulated other comprehensive income (loss) for the three months ended March 31, 2023 and 2022 was as follows (in millions):
Three Months Ended March 31: 2023 2022
Foreign currency translation gain (loss), net of tax:
Balance at beginning of period $ (1,446) $ (1,162)
Translation adjustment (net of tax effect of $(15) and $0)
 115  (40)
Reclassification to earnings (net of tax effect of $0 and $0)
 3  — 
Balance at end of period (1,328) (1,202)
Unrealized gain (loss) on marketable securities, net of tax:
Balance at beginning of period (11) (1)
Current period changes in fair value (net of tax effect of $1 and $(2))
 5  (6)
Reclassification to earnings (net of tax effect of $1 and $0)
 2  — 
Balance at end of period (4) (7)
Unrealized gain (loss) on cash flow hedges, net of tax:
Balance at beginning of period 167  (17)
Current period changes in fair value (net of tax effect of $(8) and $23)
 (26) 72 
Reclassification to earnings (net of tax effect of $(16) and $(9))
 (51) (29)
Balance at end of period 90  26 
Unrecognized pension and postretirement benefit costs, net of tax:
Balance at beginning of period (259) (2,098)
Net actuarial gain (loss) resulting from remeasurements of plan assets and liabilities (net of tax effect of $0 and $11)
 —  31 
Reclassification to earnings (net of tax effect of $7 and $(3))
 20  (7)
Balance at end of period (239) (2,074)
Accumulated other comprehensive income (loss) at end of period $ (1,481) $ (3,257)
Detail of the gains (losses) reclassified from accumulated other comprehensive income (loss) to the statements of consolidated income for the three months ended March 31, 2023 and 2022 is as follows (in millions):
Amount Reclassified from AOCI(1)
Affected Line Item in the Income Statement
Three Months Ended March 31: 2023 2022
Unrealized Gain (Loss) on Foreign Currency Translation:
Realized gain (loss) on business wind-down $ (3) $ —  Other expenses
Income tax (expense) benefit —  —  Income tax expense
Impact on net income (3) —  Net income
Unrealized gain (loss) on marketable securities:
Realized gain (loss) on sale of securities (3) —  Investment income and other
Income tax (expense) benefit 1  —  Income tax expense
Impact on net income (2) —  Net income
Unrealized gain (loss) on cash flow hedges:
Interest rate contracts (1) (3) Interest expense
Foreign currency exchange contracts 68  41  Revenue
Income tax (expense) benefit (16) (9) Income tax expense
Impact on net income 51  29  Net income
Unrecognized pension and postretirement benefit costs:
Prior service costs (27) (23) Investment income and other
Curtailment of benefit obligation —  33  Investment income and other
Income tax (expense) benefit 7  (3) Income tax expense
Impact on net income (20) 7  Net income
Total amount reclassified for the period $ 26  $ 36  Net income
(1) Accumulated other comprehensive income (loss)
Deferred Compensation Obligations and Treasury Stock
We maintain a deferred compensation plan whereby certain employees were previously able to elect to defer the gains on stock option exercises by deferring the shares received upon exercise into a rabbi trust. The shares held in this trust are classified as treasury stock, and the liability to participating employees is classified as Deferred compensation obligations within Shareowners’ Equity in the consolidated balance sheets. The number of shares needed to settle the liability for deferred compensation obligations is included in the denominator in both the basic and diluted earnings per share calculations. Employees are generally no longer able to defer the gains from stock options exercised subsequent to December 31, 2004.
Activity in the deferred compensation program for the three months ended March 31, 2023 and 2022 was as follows (in millions):
2023 2022
Three Months Ended March 31: Shares Dollars Shares Dollars
Deferred Compensation Obligations:
Balance at beginning of period $ 13  $ 16 
Reinvested dividends —  — 
Benefit payments (4) (4)
Balance at end of period $ 9  $ 12 
Treasury Stock:
Balance at beginning of period —  $ (13) —  $ (16)
Reinvested dividends —  —  —  — 
Benefit payments —  4  —  4 
Balance at end of period —  $ (9) —  $ (12)